HelloWellness Review
Best for: price-sensitive patients ready to commit to a 3-month minimum plan
HelloWellness (hellowellness.health) is a compounded GLP-1 telehealth platform offering compounded semaglutide starting at $133/month and compounded tirzepatide starting at $166/month, with a 3-month plan minimum. Programs include a longevity provider evaluation, medication, syringes with needles + injection instructions, a private Facebook community, and fast shipping. LegitScript verification seal is displayed for the related domain hellowellness.ai.
Medium confidence · Last verified 2026-05-09 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
HelloWellness is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
HelloWellness prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Compounded semaglutide (starting, 3-mo min) | compounded | $133 |
| Compounded tirzepatide (starting, 3-mo min) | compounded | $166 |
✓ Pros
- •$133/month starting price for compounded semaglutide is in the cheapest decile of the US compounded telehealth market
- •$166/month starting price for compounded tirzepatide is competitive with established compounded-tirz platforms
- •Includes syringes with needles + injection instructions in every shipment
- •Cancel anytime after 3-month minimum disclosed clearly
- •Private Facebook community provides patient support touchpoint
✗ Cons
- •3-month plan minimum (not month-to-month) — patients pay for 3 months even if they discontinue early in the program
- •LegitScript seal is for hellowellness.ai (related domain), NOT hellowellness.health — verify these are the same operating entity before purchasing
- •Parent company / legal entity NOT publicly disclosed — material YMYL transparency gap
- •Per-state availability NOT enumerated publicly
- •Pharmacy partners NOT publicly named
- •Lab work NOT disclosed in the marketing copy
Ready to start with HelloWellness?
Starting at $133/month. See current pricing and start your free consultation.
Sources & methodology
Our HelloWellness review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to HelloWellness
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with HelloWellness?
Starting at $133/month. See current pricing and start your free consultation.